Zobrazeno 1 - 5
of 5
pro vyhledávání: '"James D. Perkins, MD"'
Autor:
Daniel M. Kaufman, MD, James D. Perkins, MD, Ramasamy Bakthavatsalam, MD, Nicolae Leca, MD, Lena Sibulesky, MD, FACS
Publikováno v:
Transplantation Direct, Vol 10, Iss 8, p e1683 (2024)
Background. The number of elderly patients aged 70 y and older with liver and kidney failure is increasing, mainly because of increasing prevalence of metabolic dysfunction-associated steatohepatitis. At present, limited data are available on the out
Externí odkaz:
https://doaj.org/article/946ff26add634c969786ea675f233ea8
Autor:
Christopher J. Little, MD, Scott W. Biggins, MD, James D. Perkins, MD, MS, Catherine E. Kling, MD, MPH
Publikováno v:
Transplantation Direct, Vol 10, Iss 6, p e1630 (2024)
Background. Small stature and female sex correlate to decreased deceased donor liver transplant (DDLT) access and higher waitlist mortality. However, efforts are being made to improve access and equity of allocation under the new continuous distribut
Externí odkaz:
https://doaj.org/article/4c5dd47c30cd4e5e8c04ed9c82eec919
Autor:
Catherine E. Kling, MD, MPH, James D. Perkins, MD, MS, Scott W. Biggins, MD, MS, Anji E. Wall, MD, PhD, Jorge D. Reyes, MD
Publikováno v:
Transplantation Direct, Vol 8, Iss 2, p e1282 (2022)
Background. The current model for end-stage liver disease-based liver allocation system in the United States prioritizes sickest patients first at the expense of long-term graft survival. In a continuous distribution model, a measure of posttransplan
Externí odkaz:
https://doaj.org/article/cabc698c62184b2ababefa281ffd8ca5
Autor:
Christopher J. Little, MD, Andre A.S. Dick, MD, MPH, James D. Perkins, MD, MSDS, Jorge D. Reyes, MD
Publikováno v:
Transplantation Direct, Vol 7, Iss 8, p e733 (2021)
Background. As the rate of early postoperative complications decline after transplant with pediatric donation after circulatory death (DCD) kidneys, attention has shifted to the long-term consequences of donor–recipient (D-R) size disparity given t
Externí odkaz:
https://doaj.org/article/fe91e73e65e44e91b08b5349d3a11282
Autor:
Ajit P. Limaye, MD, Amir A. Rahnemai-Azar, MD, Susanna M. Nazarian, MD, PhD, James D. Perkins, MD, Jorge D. Reyes, MD
Publikováno v:
Transplantation Direct, Vol 7, Iss 1, p e637 (2021)
Background. Risk factors for cytomegalovirus (CMV) viremia in CMV seropositive liver transplant recipients are incompletely defined and have focused primarily on recipient factors. We hypothesized that active CMV replication (CMV viremia) in seroposi
Externí odkaz:
https://doaj.org/article/11e326e0e7c84864be6e34838eeaedce